| PERIOD ENDING | 31-Dec-07 | 31-Dec-06 | 31-Dec-05 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 9,492 | 6,870 | 345 | | | Gross Profit | (9,492) | (6,870) | (345) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,196 | 5,615 | 871 | | Non Recurring | (5,839) |
-
|
-
| | Others | 217 | 19 | 0 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,067) | (12,504) | (1,217) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,918) | 328 | 20 | | Earnings Before Interest And Taxes | (13,322) | (11,923) | (1,197) | | Interest Expense | 7 |
-
| 4 | | Income Before Tax | (13,329) | (11,923) | (1,201) | | Income Tax Expense | 1,333 | (191) |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,919) | (11,984) | (1,201) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,919) | (11,984) | (1,201) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,919) | ($11,984) | ($1,201) |
|
0.51% Nasdaq 
Income Statement
